复发性小细胞肺癌的治疗选择：我们取得了哪些进展？ - Suppr

Suppr

超能文献

Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?

作者信息

Qin Angel, Kalemkerian Gregory P

机构信息

University of Michigan, Ann Arbor, MI.

出版信息

J Oncol Pract. 2018 Jun;14(6):369-370. doi: 10.1200/JOP.18.00278.

DOI:10.1200/JOP.18.00278

PMID:29894661

Abstract

摘要

相似文献

Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?

J Oncol Pract. 2018 Jun;14(6):369-370. doi: 10.1200/JOP.18.00278.

Combination chemotherapy for relapsed small-cell lung cancer.

Lancet Oncol. 2016 Aug;17(8):1033-1035. doi: 10.1016/S1470-2045(16)30160-7. Epub 2016 Jun 14.

New opportunities in a challenging disease: lurbinectedin for relapsed small-cell lung cancer.

Lancet Oncol. 2020 May;21(5):605-607. doi: 10.1016/S1470-2045(20)30097-8. Epub 2020 Mar 27.

Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802.

Respir Investig. 2014 May;52(3):190-4. doi: 10.1016/j.resinv.2013.12.005. Epub 2014 Jan 28.

Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial.

Clin Transl Oncol. 2018 Jun;20(6):768-774. doi: 10.1007/s12094-017-1787-y. Epub 2017 Nov 2.

Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.

Lancet Oncol. 2016 Aug;17(8):1147-1157. doi: 10.1016/S1470-2045(16)30104-8. Epub 2016 Jun 14.

Efficacy and safety of amurubicin for the elderly patients with refractory relapsed small cell lung cancer as third-line chemotherapy.

J Cancer Res Ther. 2012 Apr-Jun;8(2):266-71. doi: 10.4103/0973-1482.98983.

A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients.

Cancer Chemother Pharmacol. 2017 Sep;80(3):615-622. doi: 10.1007/s00280-017-3403-9. Epub 2017 Jul 31.

Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.

Clin Lung Cancer. 2017 Mar;18(2):234-240.e2. doi: 10.1016/j.cllc.2016.09.005. Epub 2016 Oct 25.

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.

J Transl Med. 2016 May 3;14(1):111. doi: 10.1186/s12967-016-0861-5.

引用本文的文献

Real-World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small-Cell Lung Cancer Receiving Third-Line Treatment.

Cancer Rep (Hoboken). 2025 Aug;8(8):e70289. doi: 10.1002/cnr2.70289.

Synergistic effect of a nonsteroidal anti-inflammatory drug in combination with topotecan on small cell lung cancer cells.

Mol Biol Rep. 2024 Jan 18;51(1):145. doi: 10.1007/s11033-023-09055-3.

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer.

J Hematol Oncol. 2023 Jun 24;16(1):66. doi: 10.1186/s13045-023-01464-y.

Current therapy and development of therapeutic agents for lung cancer.

Cell Insight. 2022 Feb 9;1(2):100015. doi: 10.1016/j.cellin.2022.100015. eCollection 2022 Apr.

Antigene Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance.

Cancers (Basel). 2023 Feb 3;15(3):990. doi: 10.3390/cancers15030990.

PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.

Oncogene. 2022 Aug;41(33):4003-4017. doi: 10.1038/s41388-022-02391-x. Epub 2022 Jul 8.

Nonpungent N-AVAM Capsaicin Analogues and Cancer Therapy.

J Med Chem. 2021 Feb 11;64(3):1346-1361. doi: 10.1021/acs.jmedchem.0c01679. Epub 2021 Jan 28.

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Adv Ther. 2021 Jan;38(1):350-365. doi: 10.1007/s12325-020-01538-0. Epub 2020 Oct 29.

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II.

Cancers (Basel). 2020 Oct 5;12(10):2863. doi: 10.3390/cancers12102863.

Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study.

PeerJ. 2019 Dec 3;7:e8163. doi: 10.7717/peerj.8163. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验